31.05.2022 LANXESS Aktiengesellschaft  DE0005470405

DGAP-Adhoc: LANXESS Aktiengesellschaft: LANXESS and Advent establish a leading global joint venture for high-performance plastics


 

DGAP-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Strategic Company Decision/Joint Venture
LANXESS Aktiengesellschaft: LANXESS and Advent establish a leading global joint venture for high-performance plastics

31-May-2022 / 08:02 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad hoc according to  Art. 17 paragraph 1 MMVO

LANXESS and Advent International establish a leading global joint venture for high-performance engineering polymers
  • LANXESS transfers High-Performance Materials business into joint venture
  • LANXESS High Performance Materials business valued at EUR 2.5 billion.
  • LANXESS receives a payment of at least EUR 1.1 billion at closing and a stake of up to 40 percent in the joint venture
  • LANXESS and Advent to acquire Engineering Materials business from DSM for a purchase price of around EUR 3.7 billion financed by Advent. This business will also be contributed to the new joint venture
  • Substantial synergies expected
  • LANXESS to use proceeds for debt reduction and share buy back
  • New joint venture with pioneering product portfolio and integrated value chain

Specialty chemicals company LANXESS and Advent International (“Advent”) are establishing a joint venture for engineering and high-performance polymers.
LANXESS contributes its High Performance Materials (HPM) business unit which is valued at EUR 2.5 billion to the joint venture and will receive an initial payment of at least EUR 1.1 billion and a share of up to 40 percent in the future joint venture. Advent will hold at least 60 percent of the joint venture. LANXESS plans to use the proceeds for debt reduction and for a share buy-back in the amount of up to EUR 300 million.

LANXESS will have the possibility to divest the remaining stake in the joint venture to Advent earliest after three years. An earnings-related multiplier (EBITDA multiple) has already been agreed for its valuation. The EBITDA could then be significantly higher than today, as Advent and LANXESS anticipate substantial synergies resulting from the combination of the two businesses by 2026.

At the same time LANXESS and Advent signed an agreement to acquire the Engineering Materials business (DEM) from Dutch group Royal DSM, which will become part of the new joint venture. The purchase price is around EUR 3.7 billion and will be financed by the joint venture via equity from Advent and external debt. The business represents sales of around EUR 1.5 billion with an EBITDA margin of approximately 20 percent. DEM is one of the leading global suppliers high performance specialty materials that address key market needs in electronics, electrical and consumer goods.

The transaction is still subject to approval by the relevant authorities. Closing is expected in the first half of 2023.

Contact:
André Simon

LANXESS AG
Head of Investor Relations

Kennedyplatz 1
50569 Köln, Deutschland
Telefon: +49 221 8885-3494
Fax: +49 221 8885-4944
E-Mail: [email protected]

31-May-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: LANXESS Aktiengesellschaft
Kennedyplatz 1
50569 Cologne
Germany
Phone: +49 (0)221 8885-3494
Fax: +49 (0)221 8885-4944
E-mail: [email protected]
Internet: www.lanxess.com
ISIN: DE0005470405
WKN: 547040
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1364633

 
End of Announcement DGAP News Service

1364633  31-May-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1364633&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 7.699,00 6.530,00 7.197,00 6.802,00 6.104,00 7.557,00 7.660,00
EBITDA1,2 995,00 709,00 935,00 910,00 757,00 863,00 1.100,00
EBITDA-Marge3 12,92 10,86 12,99 13,38 12,40 11,42 14,36
EBIT1,4 464,00 299,00 504,00 407,00 253,00 350,00 560,00
EBIT-Marge5 6,03 4,58 7,00 5,98 4,14 4,63 7,31
Jahresüberschuss1 195,00 124,00 523,00 191,00 902,00 267,00 384,00
Netto-Marge6 2,53 1,90 7,27 2,81 14,78 3,53 5,01
Cashflow1,7 689,00 868,00 586,00 643,00 585,00 407,00 0,00
Ergebnis je Aktie8 2,10 0,95 4,71 2,32 10,22 3,09 2,55
Dividende8 0,70 0,80 0,90 0,95 1,00 1,05 0,70
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Lanxess
WKN Kurs in € Einschätzung Börsenwert in Mio. €
547040 36,000 Halten 3.108,47
KGV 2023e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
12,41 17,95 0,71 12,74
KBV KCV KUV EV/EBITDA
0,85 7,64 0,41 6,65
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,70 0,70 1,94 24.05.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
10.05.2023 04.08.2023 09.11.2022 15.03.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
2,99% -1,42% -33,95% -31,82%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu LANXESS Aktiengesellschaft  ISIN: DE0005470405 können Sie bei EQS abrufen


Chemie , 547040 , LXS , XETR:LXS